Clinical utility of evaluating intracranial artery stenosis and silent brain infarction to predict the presence of subclinical coronary artery disease in ischemic stroke patients

Internal Medicine

Volumn 47, Issue 20, 2008, Pages 1775-1781

  Hoshino, Atsushi ^a   Nakamura, Takashi ^b   Enomoto, Satoko ^a   Kawahito, Hiroyuki ^a   Kurata, Hiroyuki ^b   Nakahara, Yoshifumi ^b   Ijichi, Toshiharu ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Medical Care Center   (Japan)

Author keywords

Coronary artery disease; Coronary computed tomographic angiography; Intracranial artery stenosis; Magnetic resonance angiography; Magnetic resonance imaging; Silent brain infarction

Indexed keywords

AGED; ARTICLE; BRAIN DAMAGE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR;

AGED; BRAIN INFARCTION; CONSTRICTION, PATHOLOGIC; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTRACRANIAL ARTERIAL DISEASES; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 56349085933     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.1314     Document Type: Article

References (41)

1. White H, Boden-Albala B, Wang C, et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation 111: 1327-1331, 2005.
2. Rokey R, Rolak LA, Harati Y, Kutka N, Verani MS. Coronary artery disease in patients with cerebrovascular disease: a prospective study. Ann Neurol 16: 50-53, 1984.
3. Chimowitz MI, Poole RM, Starling MR, Schwaiger M, Gross MD. Frequency and severity of asymptomatic coronary disease in patients with different causes of stroke. Stroke 28: 941-945, 1997.
4. Love BB, Grover-McKay M, Biller J, Rezai K, McKay CR. Coronary artery disease and cardiac events with asymptomatic and symptomatic cerebrovascular disease. Stroke 23: 939-945, 1992.
5. Di Pasquale G, Pinelli G, Grazi P, et al. Incidence of silent myocardial ischaemia in patients with cerebral ischaemia. Eur Heart J 9 Suppl N: 104-107, 1988.
6. Albers GW. Choice of endpoints in antiplatelet trials: which outcomes are most relevant to stroke patients? Neurology 54: 1022-1028, 2000.
7. Hankey GJ, Jamrozik K, Broadhurst RJ, et al. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke 31: 2080-2086, 2000.
8. Hartmann A, Rundek T, Mast H, et al. Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology 57: 2000-2005, 2001.
9. Touzé E, Varenne O, Chatellier G, Peyrard S, Rothwell PM, Mas JL. Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke 36: 2748-2755, 2005.
10. Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 66: 1187-1191, 2006.
11. Vermeer SE, Hollander M, van Dijk EJ, Hofman A, Koudstaal PJ, Breteler MM. Rotterdam Scan Study. Silent brain infarcts and white matter lesions increase stroke risk in the general population: the Rotterdam Scan Study. Stroke 34: 1126-1129, 2003.
12. Bokura H, Kobayashi S, Yamaguchi S, et al. Silent brain infarction and subcortical white matter lesions increase the risk of stroke and mortality: a prospective cohort study. J Stroke Cerebrovasc Dis 15: 57-63, 2006.
13. Uekita K, Hasebe N, Funayama N, et al. Cervical and intracranial atherosclerosis and silent brain infarction in Japanese patients with coronary artery disease. Cerebrovasc Dis 16: 61-68, 2003.
14. Li AH, Chu YT, Yang LH, Chen KC, Chu SH. More coronary artery stenosis, more cerebral artery stenosis? A simultaneous angiographic study discloses their strong correlation. Heart Vessels 22: 297-302, 2007.
15. Hara M, Ito K, Nawata T, et al. Silent cerebral infarction associated with coronary artery disease. Cardiology 85: 171-174, 1994.
16. Modrego Pardo PJ, Labrador Fuster T, Torres Nuez J. Silent brain infarctions in patients with coronary heart disease. A Spanish population survey. J Neurol 245: 93-97, 1998.
17. Hoshino A, Nakamura T, Enomoto S, et al. Prevalence of coronary artery disease in Japanese patients with cerebral infarction. Circ J 72: 404-408, 2008.
18. Bokura H, Kobayashi S, Yamaguchi S. Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study. J Neurol 245: 116-122, 1998.
19. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Roentgenol 149: 351-356, 1987.
20. Levey AS, Coresh J, Greene T, et al. Chronic Kidney Disease Epidemiology Collaboration. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247-254, 2006.
21. Mathur KS, Kashyap SK, Kumar V. Correlation of the extent and severity of atherosclerosis in the coronary and cerebral arteries. Circulation 27: 929-934, 1963.
22. Gongora-Rivera F, Labreuche J, Jaramillo A, Steg PG, Hauw JJ, Amarenco P. Autopsy prevalence of coronary atherosclerosis in patients with fatal stroke. Stroke 38: 1203-1210, 2007.
23. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 6: 611-619, 2007.
24. Shinkawa A, Ueda K, Kiyohara Y, et al. Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study. Stroke 26: 380-385, 1995.
25. Boon A, Lodder J, Heuts-van Raak L, Kessels F. Silent brain infarcts in 755 consecutive patients with a first-ever supratentorial ischemic stroke. Relationship with index-stroke subtype, vascular risk factors, and mortality. Stroke 25: 2384-2390, 1994.
26. Longstreth WT Jr, Dulberg C, Manolio TA, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 33: 2376-2382, 2002.
27. Adachi T, Kobayashi S, Yamaguchi S. Frequency and pathogenesis of silent subcortical brain infarction in acute first-ever ischemic stroke. Intern Med 41: 103-108, 2002.
28. Boiten J, Lodder J, Kessels F. Two clinically distinct lacunar infarct entities? A hypothesis. Stroke 24: 652-656, 1993.
29. Vermeer SE, Den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Rotterdam Scan Study. Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 34: 392-896, 2003.
30. Kwon HM, Kim BJ, Lee SH, Choi SH, Oh BH, Yoon BW. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke 37: 466-470, 2006.
31. Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H, Hori M. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 36: 768-772, 2005.
32. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 348: 1215-1222, 2003.
33. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review. Stroke 26: 1293-1301, 1995.
34. van Swieten JC, van den Hout JH, van Ketel BA, Hijdra A, Wokke JH, van Gijn J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly. A morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 114: 761-774, 1991.
35. Janota I, Mirsen TR, Hachinski VC, Lee DH, Merskey H. Neuropathologic correlates of leuko-araiosis. Arch Neurol 46: 1124-1128, 1989.
36. Estes ML, Chimowitz MI, Awad IA, McMahon JT, Furlan AJ, Ratliff NB. Sclerosing vasculopathy of the central nervous system in nonelderly demented patients. Arch Neurol 48: 631-636, 1991.
37. Takao M, Koto A, Tanahashi N, Fukuuchi Y, Takagi M, Morinaga S. Pathologic findings of silent hyperintense white matter lesions on MRI. J Neurol Sci 167: 127-131, 1999.
38. Breteler MM, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 44: 1246-1252, 1994.
39. Bots ML, van Swieten JC, Breteler MM, et al. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 341: 1232-1237, 1993.
40. Kitamura A, Nakagawa Y, Sato M, et al. Proportions of stroke subtypes among men and women > or =40 years of age in an urban Japanese city in 1992, 1997, and 2002. Stroke 37: 1374-1378, 2006.
41. Okada K, Kobayashi S; Japanese Standard Stroke Registry Study (JSSRS) Group. The present state of acute ischemic stroke therapy in Japan. Intern Med 44: 365-368, 2005.